Skip to main content
. 2023 Sep 23;6(1):100914. doi: 10.1016/j.jhepr.2023.100914

Table 1.

Baseline characteristics.

Baseline characteristics TIPS cohort (n = 64) Control cohort (n = 131)
Sex: male/female (n, %) 42 (66)/22 (34) 80 (61)/51 (39)
Age (years) 55.5 (48.0, 63.0) 63.0 (54.0, 72.0)
BMI (kg/m2) 26.0 (22.6, 29.0) 26.3 (22.7, 31.8)
Aetiology (n, %)
 ALD 38 (59) 38 (29)
 Viral 11 (17) 28 (21)
 NASH 3 (5) 16 (12)
 PBC/PSC/AIH 8 (13) 11 (8)
 Cryptogenic and other 4 (6) 38 (29)
Child-Pugh score A/B/C/n.a. (n, %) 14 (22)/37 (58)/12 (19)/1 (2) 37 (28)/70 (53)/18 (14)/6 (5)
History of SBP (n, %) 11 (17) 12 (10)
History of HRS (n, %) 19 (30) 19 (15)
History of HE (n, %) 26 (41) 19 (15)
History of GI bleeding (n, %) 29 (45) 26 (20)
Variceal size 0/I/II/III/n.a. (n, %) 9 (14)/15 (23)/17 (27)/7 (11)/16 (25) 42 (32)/31 (24)/17 (13)/4 (3)/37 (28)
 Red spots: yes/no/unknown (n, %) 13 (20)/25 (39)/26 (41) 13 (10)/55 (42)/63 (48)
NSBB treatment (n, %) n.a. 27 (21)

Data are shown as counts and percentages as indicated or median values with the 0.25- and 0.75-quartile. Baseline characteristics were similar between the two cohorts.

AIH, autoimmune hepatitis; ALD, alcohol-related liver disease; GI, gastrointestinal; HE, hepatic encephalopathy; HRS, hepatorenal syndrome; n.a., not available; NASH, non-alcoholic steatohepatitis; NSBB, non-selective beta-blockers; PBC, primary biliary cholangitis; PSC, primary sclerosing cholangitis; SBP, spontaneous bacterial peritonitis; TIPS, transjugular intrahepatic portosystemic shunt.